CMS Open Payments · Program Year 2024
Ferring SA de CV
Ferring SA de CV reported $18,026.97 across General Payments, Research, and Ownership to 10 physicians and teaching hospitals across 10 transactions.
- $18.0K Below-median payer
- All-tracks total
- 10 Below-median volume
- Transactions
- 10 Below-median reach
- Recipients
- #1548
- of 1,925 companies
Ferring SA de CV reported $18,026.97 across all CMS Open Payments tracks (General + Research + Ownership) to 10 physicians and teaching hospitals in Program Year 2024 - ranking #1548 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $18,026.97, averaging $1.8K per recipient.
Ferring SA de CV's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
17/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
37/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer ferring-sa-de-cv Ferring SA de CV
$18.0K · #1548/1,925 · 0.0% industry · PY2024
- TOT $18.0K
- RANK #1548
- SHARE 0.0%
- TXN 10
- RCP 10
- CAT 3
- GEN $18.0K
- TOP1 51.3%
- PY 2024
Volume peers
Nearest volume peer: Solco Biomedical Corporation ($18.0K)
Ferring SA de CV sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Ferring SA de CV
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Ferring SA de CV that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
2 transactions worth $13.3K make "Consulting Fee" the top general-payment category in the 3-category breakdown below, 73.9% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Ferring SA de CV's 3-category general-payment breakdown at $13.3K, 73.9% of the reported total.
How Ferring SA de CV divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $13.3K | 2 | 73.9% |
| Travel and Lodging | $3.8K | 6 | 21.1% |
| Food and Beverage | $893.90 | 2 | 5.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $18,026.97 (100.0%) of $18,026.97 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Ferring SA de CV
The five named recipients with the highest reported General Payments from this company
- 1
Richard Legro
$9,239.32 across 5 reported transactions
- 2
Julio Loret de Mola
$8,787.65 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Ferring SA de CV ranks #1548 of 1,925 by total payments (bottom 20% by spend) but is notably more concentrated than that alone would suggest -- #359 of 1,838 by HHI (top 20% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Teleflex Incorporated : $670.6K total payments, HHI 5042
- nView medical, Inc : $169.96 total payments, HHI 5033
- Asuragen, Inc. : $4.9K total payments, HHI 5032
- Medynus Inc : $13.0K total payments, HHI 5030
- Spacelabs Healthcare Inc : $3.7K total payments, HHI 5019
- Mighty Oak Medical : $7.2K total payments, HHI 5008
- Ferring SA de CV (this company) : $18.0K total payments, HHI 5003
- Cutting Edge Spine, LLC : $13.3K total payments, HHI 5002
- Episurf Medical, Inc. : $15.1K total payments, HHI 5002
- Luminex Corporation : $2.3K total payments, HHI 5001
- Dentsply Sirona KK : $32.4K total payments, HHI 5000
- Rochester Medical Corporation : $54.76 total payments, HHI 5000
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Ferring SA de CV's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Ferring SA de CV.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Ferring SA de CV.
Showing 6 of 1,924 companies with CMS-reported payment data.
Centrix Inc
Avantec Vascular Corporation
Ostial Corporation
Bayer Puerto Rico Inc.
Jubilant DraxImage Inc.
Put this to use
Ferring SA de CV ranks #1548 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Ferring SA de CV. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.